The Humanness of Macaque Antibody Sequences

Journal of Molecular Biology

Volumn 396, Issue 5, 2010, Pages 1439-1450

  Thullier, Philippe ^a   Huish, Oliver ^b   Pelat, Thibaut ^a   Martin, Andrew C R ^b  

^a CENTRE DE RECHERCHES   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti antibody response; Human anti mouse antibody response; Humanization; Immunogenicity; Patent

Indexed keywords

ANTIBODY; ANTIGEN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ALLELE; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC DATABASE; GERM LINE; HEAVY CHAIN; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOGENICITY; LIGHT CHAIN; MACACA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEQUENCE ANALYSIS;

MACACA FASCICULARIS;

EID: 77649272592     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.12.041     Document Type: Article

References (21)

1. Hwang W.Y.K., Foote J. Immunogenicity of engineered antibodies. Methods 2005, 36:3-10.
2. Morrison S.L., Johnson M.J., Herzenberg L.A., Oi V.T. Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl Acad. Sci. USA 1984, 81:6851-6855.
3. Verhoeyen M., Milstein C., Winter G. Reshaping human antibodies: grafting an antilysozyme activity. Science 1988, 239:1534-1536.
4. Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature (London) 1988, 332:323-327.
5. Lorenz H.M. Technology evaluation: Adalimumab, Abbott laboratories. Curr. Opin. Mol. Ther. 2002, 4:185-190.
6. Schellekens H. Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin. Ther. 2002, 24:1720-1740.
7. De Groot A.S., Scott D.W. Immunogenicity of protein therapeutics. Trends Immunol. 2007, 28:482-490.
8. Abhinandan K.R., Martin A.C.R. Analyzing the "degree of humanness" of antibody sequences. J. Mol. Biol. 2007, 369:852-862.
9. Johnson G., Wu T.T. Kabat Database and its applications: future directions. Nucleic Acids Res. 2001, 29:205-206.
10. Pelat T., Bedouelle H., Rees A.R., Crennell S.J., Lefranc M.-P., Thullier P. Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J. Mol. Biol. 2008, 384:1400-1407.
11. Giudicelli V., Chaume D., Lefranc M.-P. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 2005, 33:D256-D261.
12. Lefranc M.-P., Giudicelli V., Ginestoux C., Jabado-Michaloud J., Folch G., Bellahcene F., et al. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 2009, 37:D1006-D1012.
13. Schütte M., Thullier P., Pelat T., Wezler X., Rosenstock P., Hinz D., et al. Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One 2009, 4:e6625.
14. Pelat T., Hust M., Laffly E., Condemine F., Bottex C., Vidal D., et al. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob. Agents Chemother. 2007, 51:2758-2764.
15. Laffly E., Danjou L., Condemine F., Vidal D., Drouet E., Lefranc M.-P., et al. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob. Agents Chemother. 2005, 49:3414-3420.
16. Chassagne S., Laffly E., Drouet E., Hérodin F., Lefranc M.-P., Thullier P. A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library. Mol. Immunol. 2004, 41:539-546.
17. Pelat T., Hust M., Hale M., Lefranc M.-P., Dübel S., Thullier P. Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol. 2009, 9:60.
18. Pelat T., Thullier P. Non-human primate immune libraries combined with germline humanization: an (almost) new, and powerful approach for the isolation of therapeutic antibodies. Mabs 2009, 4:377-381. http://www.landesbioscience.com/journals/mabs/article/8635.
19. Martin A.C. Accessing the Kabat antibody sequence database by computer. Proteins Struct. Funct. Genet. 1996, 25:130-133.
20. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
21. Pearson W.R., Lipman D.J. Improved tools for biological sequence comparison. Proc. Natl Acad. Sci. USA 1988, 85:2444-2448.